Day 1 - Immunology & Vaccines
Innate immunity and hostdirected therapies; Tom Hawn
Adaptive immunity to M.tuberculosis; Chetan Seshadri
Granulomas and in vivo model of TB pathogenesis: dissecting mechanisms of protection and dissemination; Kevin Urdahl
TB controlled human infection model (TB-CHIM); Rhea Coler
TB vaccine trials; Andrew Fiore-Gartland
Session 1 Panel Discussion
Day 2 - Pathogenesis & Treatment
Pathogenesis and drug targets; David Sherman
Systems biology approaches to drug discovery; Nitin Baliga
Drug discovery and development; Arielle Butts
Treatment regimens, including PLHIV; Adrienne Shapiro
Treatment for drug-resistant and extrapulmonary; Bijan Ghassemieh
Session 2 Panel Discussion
Day 3 - Biomarkers, Diagnostics & TB Advocacy
TB biomarkers and diagnostics; Paul Drain
Novel biomarkers for incipient/subclinical TB; Javeed Shah
Tongue swabs and other nonsputum based diagnostics; Jerry Cangelosi
Organizing, Funding, and Media for TB advocacy; Erin McConnell, TAG
Session 3 Panel Discussion with John Greene
Day 4 - Aerobiology, Transmission & Prevention
Aerosol biology and TB transmission; David Horne
Resister populations and Mtb transmission; Jason Simmons
Imaging and other clinical measures for risk of Mtb transmission; Engi Attia
TB preventive treatment and novel regimens; Jennifer Ross
TB in Pregnancy; Sylvia LaCourse
Session 4 Panel Discussion
Day 5 - Disease Modeling, mHealth, Pediatrics & Pregnant Women
TB modeling and phylogenetics; Josh Herbeck
Using mobile health technologies for TB; Sarah Iribarren
Pediatrics and special populations; Rafael Hernandez
Diagnostics for pregnant women and PLHIV; Grace John-Stewart